DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vznpzg/p53_signaling) has announced the addition of the "p53 Signaling Pathway in Cancer Drug Pipeline" report to their offering. p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53...
More...
